ReviewAnnals of surgical oncology2026
Series on the Lancet Oncology Commission on Global Cancer Surgery-Action 3: Research.
Review in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer surgical research is essential to discover newer treatment options, enhance survival, improve quality of care, and more importantly, impede the rising global cancer burden. The inability to conduct cancer surgical research can have detrimental health and economic effects at the individual and societal levels. It is well known that there are several barriers to conducting cancer surgical research, and these barriers are exacerbated in low-resource settings. The second Lancet Oncology Commission on Global Cancer Surgery Action on research helps to address these barriers and outline strategies that promote cancer surgical research on the global stage. METHODS AND
resultsThis study used the principles of Implementation Science taken from the Consolidated Framework for Implementation Research (CFIR) to help develop the content and increase the likelihood of success in implementing the recommendations in this Action.
conclusionThe Annals of Surgical Oncology Series on the second Lancet Oncology Commission on Global Cancer Surgery hopes to enhance the visibility of the eight critical Actions within this important Commission to the primary stakeholders, the surgeons. The authors hope this Action on research will help to address these barriers and implement resource-stratified solutions to build individual, institutional, and system-wide capacity for cancer surgical research. These efforts should lead to the development of a robust cancer surgical research infrastructure that will eventually translate to improved patient and population outcomes.
Indexed as
Identifiers
42955515What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.